Previsioni di mercato delle particelle virus-simili per il Nord America fino al 2028 – Impatto del COVID-19 e analisi regionale per tipo di prodotto (epatite, cancro/HPV e malattia di Gaucher), fonte (lievito, cellule di insetti, piante e altri) e applicazione (vaccini) e terapeutico)

Introduzione al mercato

L\'analisi del mercato delle particelle virus-simili nel Nord America si basa su tre principali paesi: Stati Uniti, Canada e Messico. Tra le province del Nord America, gli Stati Uniti detengono la dimensione maggiore del mercato VLP a causa delle infezioni virali segnalate, ad esempio, varianti del virus dell\'influenza. Secondo i Centri per il controllo e la prevenzione delle malattie (CDC), la maggior parte delle condizioni di varianti virali si sono verificate principalmente in bambini di età pari o inferiore a 18 anni con l\'insorgenza della malattia, secondo il rapporto dei Centri per il controllo e la prevenzione delle malattie ( CENTRO PER LA PREVENZIONE E IL CONTROLLO DELLE MALATTIE). Inoltre, le costanti attività di ricerca e sviluppo per la produzione di vaccini vivi attenuati da parte dell\'azienda biofarmaceutica hanno un impatto positivo sulla crescita del mercato.

Nelle province del Nord America, gli Stati Uniti sono stati il paese più colpito a causa al COVID-19. Ciò è dovuto al fatto che gli Stati Uniti hanno mostrato una risposta disomogenea durante l’insorgenza del COVID-19, unita all’insufficienza delle risorse per testare. Per superare il tasso di trasmissione del COVID-19, lo sviluppo del vaccino era urgente per tutte le aziende biofarmaceutiche con un’elevata attenzione ai vaccini ricombinanti contro il COVID-19. Poiché i vaccini ricombinanti includono vaccini con proteine spike ricombinanti, vaccini ricombinanti con domini leganti i recettori e particelle simili a virus, hanno acquisito grande importanza. Inoltre, è probabile che nei prossimi anni aumenterà lo sviluppo di forme più efficaci e mirate di VLP modificando la superficie delle particelle in modo che possano essere introdotte in cellule o tessuti specifici. I recenti progressi nella produzione di VLP riguardano diversi tipi di sistemi di espressione per lo sviluppo e l\'applicazione di vaccini nella prevenzione delle malattie infettive. Nella regione del Nord America, i paesi in cui sono attualmente in fase di sviluppo i vaccini contro il COVID-19, tra cui Stati Uniti, Canada e Cuba. Tra questi paesi, gli Stati Uniti hanno undici vaccini, mentre Canada e Cuba ne possiedono tre. Inoltre, ci sono sei vaccini a subunità proteica comprendenti VLP, cinque vaccini vettoriali e cinque vaccini contro gli acidi nucleici. Ma la produzione di particelle simili a virus rimane ancora impegnativa in termini di progettazione, purificazione e stoccaggio. Le sfide sono principalmente associate alla tecnica di bioprocessamento che si occupa di problemi respiratori. Tuttavia, con il forte progresso tecnologico, nel prossimo futuro svilupperà infine una serie di candidati vaccini basati su VLP nuovi, stabili ed efficienti.

Panoramica del mercato e Dynamics

Si prevede che il mercato delle particelle virus-simili in Nord America crescerà da 1.928,37 milioni di dollari nel 2021 a 3.312,49 milioni di dollari entro 2028; si stima che crescerà a un CAGR dell\'8,0% dal 2021 al 2028. Vari attori del mercato sanitario e organizzazioni di ricerca sono attivamente coinvolti nelle innovazioni e nello sviluppo dei prodotti. L’uso di particelle simili a virus è un approccio emergente utilizzato nell’industria biofarmaceutica. Poiché le particelle simili a virus sono prive del contenuto virale, sono più facili da gestire rispetto ai componenti virali effettivi. I VLP possono essere utilizzati per facilitare la somministrazione di farmaci, l\'imaging, l\'immunoterapia e la terapia terapeutica. Ad esempio, secondo uno studio pubblicato dall\'NCBI nel giugno 2020, la VLP può essere utilizzata sotto forma di nanoparticelle in applicazioni quali terapia fototermica, imaging PET e TC, vettori di agenti di contrasto per MRI, imaging ottico, vaccini per malattie infiammatorie e autoimmuni, immunoterapia antitumorale e somministrazione di farmaci a piccole molecole (nella terapia antitumorale). Pertanto, si prevede che tali potenziali applicazioni dei VLP forniranno opportunità di crescita agli operatori del mercato durante il periodo di previsione.

Segmenti chiave del mercato

In termini di tipologia di prodotto, il segmento dell\'epatite ha rappresentato la quota maggiore del mercato delle particelle virus-simili in Nord America nel 2021. In termini di fonte, il segmento del lievito ha rappresentato la quota maggiore del mercato delle particelle simili a virus in Nord America nel 2021. In termini di applicazione, il segmento dei vaccini ha detenuto una quota di mercato maggiore del mercato delle particelle simili a virus nel 2021.

Principali fonti e società elencate

Alcune delle principali fonti primarie e secondarie citate per la preparazione di questo rapporto su Il mercato delle particelle virus-simili in Nord America comprende siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali società elencate nel rapporto sono Merck & Co., Inc.; GlaxoSmithKline plc.; Pfizer Inc.; Sanofi; Istituto del siero dell\'India Pvt. Ltd.; BIOTECNOLOGIA BHARAT; LG Chem; VBI Vaccini Inc.; e Dynavax Technologies tra gli altri.

Motivi per acquistare il rapporto

Comprendere il panorama del mercato delle particelle simili ai virus in Nord America e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
Stai al passo con la corsa comprendendo il panorama competitivo in continua evoluzione per il mercato delle particelle simili ai virus in Nord America
In modo efficiente pianificare fusioni, acquisizioni e accordi di partnership nel mercato delle particelle simili a virus in Nord America identificando i segmenti di mercato con le vendite probabili più promettenti
Aiuta a prendere decisioni aziendali consapevoli grazie ad un\'analisi perspicace e completa della performance di mercato di vari segmenti del mercato delle particelle simili a virus del Nord America
Ottenere previsioni sui ricavi di mercato per il mercato in base ai vari segmenti dal 2021 al 2028 nella regione del Nord America.

Segmentazione del mercato delle particelle simili a virus nel Nord America

Mercato delle particelle simili a virus in Nord America: per tipo di prodotto

Epatite
Cancro/HPV
Malattia di Gaucher

Mercato delle particelle simili a virus in Nord America - Per fonte

Lievito
Cellula di insetto
Pianta
Altri

Mercato delle particelle simili a virus in Nord America - Di Applicazione

Vaccini
Therapeutics

Mercato delle particelle simili a virus in Nord America - Per Paese

Stati Uniti
Canada
Messico

Mercato delle particelle virali in Nord America - Aziende Menzionato

Introduction
1.1         Scope of the Study
1.2         The Insight Partners Research Report Guidance
1.3         Market Segmentation
1.3.1        North America Virus-like Particles Market – By Product Type
1.3.2        North America Virus-like Particles Market – By Source
1.3.3        North America Virus-like Particles Market – By Application
1.3.4        North America Virus-like Particles Market – By Country
2.           North America Virus-like Particles Market – Key Takeaways
3.        Research Methodology
3.1         Coverage
3.2         Secondary Research
3.3         Primary Research
4.           North America Virus-like Particles Market Landscape
4.1         Overview
4.2         PEST Analysis
4.3         Experts Opinion
5.           North America Virus-like Particles Market – Key Market Dynamics
5.1         Market Drivers
5.1.1        Growing Prevalence of Infectious Viral Diseases
5.1.2        The Elevating Role of Virus-Like Particles in Therapeutic Developments and Studies
5.2         Market Restraints
5.2.1        Presence of Alternative Technologies for Viral Vaccine Production
5.3         Market Opportunities
5.3.1        Raising Potential Applications in Therapeutics and Diagnostics
5.4         Future Trends
5.4.1        Constant Demand for Innovative and Effective Products
5.5         Impact Analysis
6.           North America Virus-like Particles Market Analysis
6.1         North America Virus-like Particles Market Revenue Forecast and Analysis
7.           North America Virus-like Particles Market Analysis – by Product Type
7.1         Overview
7.2         North America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
7.3         Hepatitis
7.3.1        Overview
7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.4         Cancer/ Human Papillomavirus (HPV)
7.4.1        Overview
7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.5         Gaucher Disease
7.5.1        Overview
7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.           North America Virus-like Particles Market Analysis – By Source
8.1         Overview
8.2         North America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
8.3         Yeast
8.3.1        Overview
8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.4         Plant
8.4.1        Overview
8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.5         Insect Cell
8.5.1        Overview
8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.6         Others
8.6.1        Overview
8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.           North America Virus-like Particles Market Analysis – By Application
9.1         Overview
9.2         North America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
9.3         Vaccines
9.3.1        Overview
9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.4         Therapeutics
9.4.1        Overview
9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.        North America Virus-like Particles Market – Country Analysis
10.1      Overview
10.1.1     North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)
10.1.1.1       US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1       Overview
10.1.1.1.2       US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3       US: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.1.4       US: Virus-like Particles Market, by Source, 2019–2028 (US$ Million)
10.1.1.1.5       US: Virus-like Particles Market, by Application, 2019–2028 (US$ Million)
10.1.1.2       Canada: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1       Overview
10.1.1.2.2       Canada: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3       Canada: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.2.4       Canada: Virus-like Particles Market, by Source, 2019–2028 (US$ Million)
10.1.1.2.5       Canada Virus-Like Particles Market, by Application, 2019–2028 (US$ Million)
10.1.1.3       Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1       Overview
10.1.1.3.2       Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3       Mexico: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.3.4       Mexico: Virus-like Particles Market, by Source, 2019–2028 (US$ Million)
10.1.1.3.5       Mexico: Virus-like Particles Market, by Application, 2019–2028 (US$ Million)
11.        Impact Of COVID-19 Pandemic on North America Virus-like Particles Market
11.1      North America: Impact Assessment of COVID-19 Pandemic
12.        North America Virus-like Particles Market–Industry Landscape
12.1      Overview
12.2      Organic Developments
12.2.1     Overview
12.3      Inorganic Developments
12.3.1     Overview
13.        Company Profiles
13.1      Merck & Co., Inc.
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2      GlaxoSmithKline plc.
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3      Pfizer Inc.
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4      Dynavax Technologies
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5      Sanofi
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6      Serum Institute of India Pvt. Ltd.
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7      BHARAT BIOTECH
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
13.8      LG Chem
13.8.1     Key Facts
13.8.2     Business Description
13.8.3     Products and Services
13.8.4     Financial Overview
13.8.5     SWOT Analysis
13.8.6     Key Developments
13.9      VBI Vaccines Inc.
13.9.1     Key Facts
13.9.2     Business Description
13.9.3     Products and Services
13.9.4     Financial Overview
13.9.5     SWOT Analysis
13.9.6     Key Developments
14.        Appendix
14.1      About The Insight Partners
14.2      Glossary of Terms

LIST OF TABLES
Table 1.             North America Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)
Table 2.             US Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 3.             US Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 4.             US Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Million)
Table 5.             Canada: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 6.             Canada Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 7.             Canada Virus-Like Particles Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8.             Mexico: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 9.             Mexico Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 10.          Mexico Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Million)
Table 11.          Organic Developments Done by Companies
Table 12.          Inorganic Developments Done by Companies
Table 13.          Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES
Figure 1.           North America Virus-like particles Market Segmentation
Figure 2.           North America Virus-like particles Market Segmentation, By Country
Figure 3.           North America Virus-like Particles Market Overview
Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in North America Virus-like particles Market
Figure 5.           The US to Show Significant Growth during Forecast Period
Figure 6.           North America Virus-like Particles Market, Industry Landscape
Figure 7.           North America PEST Analysis
Figure 8.           North America Virus-like Particles Market: Impact Analysis of Drivers and Restraints
Figure 9.           North America Virus-like Particles Market– Revenue Forecast and Analysis to 2028
Figure 10.        North America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 14.        North America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19.        North America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22.        North America: Virus-like Particles Market, by Key Country – Revenue (2021) (US$ Million)
Figure 23.        North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)
Figure 24.        US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25.        Canada: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26.        Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27.        Impact of COVID-19 Pandemic in North American Country Markets

Merck & Co., Inc.
GlaxoSmithKline plc.
Pfizer Inc.
Sanofi
Serum Institute of India Pvt. Ltd.
BHARAT BIOTECH
LG Chem
VBI Vaccines Inc.
Dynavax Technologies

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America virus-like particles market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a.. May 2022

North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele.. May 2022

North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh.. May 2022

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.